# Perimed AB, Jarfalla, Sweden – FDA Inspections

Source: https://www.keypedia.com/companies/perimed-ab/c2877ac7-60d3-41f5-8934-2d153968829e

> Inspection records and compliance data for Perimed AB in Jarfalla. 2 FDA inspections on record, last inspected January 29, 2025.

---

## Details

- Name: Perimed AB
- FEI Number: 3003244961
- Address Line 1: Datavagen 9A
- City: Jarfalla
- Country Name: Sweden
- Address: Datavagen 9A, Jarfalla, Sweden
- Country: Sweden

## Related Documents

- FDA Inspection 1265911 - Perimed AB - 2025-01-29 — source: FDA, date: January 29, 2025
- FDA Inspection 1265911 - Perimed AB - 2025-01-29 — classification: No Action Indicated (NAI), source: FDA, date: January 29, 2025
- FDA Inspection 961291 - Perimed AB - 2016-02-11 — classification: No Action Indicated (NAI), source: FDA, date: February 11, 2016

## Related Companies

- [EPISURF OPERATIONS AB](https://www.keypedia.com/companies/episurf-operations-ab/d1ae38e9-ffee-4ae6-9dfd-01f394a8f859)
- [Vitrolife Sweden AB](https://www.keypedia.com/companies/vitrolife-sweden-ab/858a164c-7970-4eec-8db8-8f8b14722939)
- [Willo AB](https://www.keypedia.com/companies/willo-ab/592124c5-2145-4f79-99e4-8726ffb1ee48)
- [Fredriksons Verkstad AB](https://www.keypedia.com/companies/fredriksons-verkstad-ab/59548e2a-92f7-4993-8a42-8c17016d65b6)
- [Sectra AB](https://www.keypedia.com/companies/sectra-ab/7b754e4c-d1d7-45ad-8e4e-9f78c2f72460)
- [Nidacon International](https://www.keypedia.com/companies/nidacon-international/28bb63c7-d83a-4f38-a066-d4b2058eb225)
- [Orkla Care AB](https://www.keypedia.com/companies/orkla-care-ab/cfe8003e-fc61-488f-a77a-2f46060d087a)
- [ONCOlog Medical QA AB](https://www.keypedia.com/companies/oncolog-medical-qa-ab/acbed3ba-4c21-4495-aae2-b94017f1bf4f)
- [Nobel Biocare AB (dba -Nobel Biocare Production)](https://www.keypedia.com/companies/nobel-biocare-ab-dba-nobel-biocare-production/e3b2d9d0-13f2-46be-8ebb-8fdc9a114ab7)
- [Medical Vision Ab](https://www.keypedia.com/companies/medical-vision-ab/b6165a4e-19ed-4b16-a940-0810e3f155c6)